Results 121 to 130 of about 48,869 (270)

Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015–2022 Influenza Seasons

Influenza and Other Respiratory Viruses, Volume 20, Issue 7, July 2026.
ABSTRACT Backgrounds The antiviral drug prescription landscape has changed as new antivirals for influenza treatment have been approved. Understanding this landscape is important to assess potential under‐ and mis‐utilization and to address gaps in care.
Kyueun Lee, Anirban Basu, Janet A. Englund   +2 more
wiley   +1 more source

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

, 2013
Amanda Kamali,1 Mark Holodniy1,21Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, USA; 2Office of Public Health, Department of Veterans Affairs, Washington, DC, USAAbstract: Influenza virus is a pathogen that causes ...
Kamali A, Holodniy M
core  

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children

Sao Paulo medical journal = Revista paulista de medicina, 2014
BACKGROUND: Neuraminidase inhibitors (NIs) are stockpiled and recommended by public health agencies for treating and preventing seasonal and pandemic influenza. They are used clinically worldwide.
T. Jefferson, Mark Jones, P. Doshi, C. Del Mar, C. Heneghan, R. Hama, Matthew J. Thompson   +6 more
semanticscholar   +1 more source

A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025

Influenza and Other Respiratory Viruses, Volume 20, Issue 7, July 2026.
ABSTRACT Background Influenza causes 650,000 deaths, 3–5 million hospitalizations, and 1 billion cases worldwide each year. There is a limited repertoire of antivirals available to tackle this burden, highlighting the risk of developing resistance to current drugs.
Alejandro Martín‐Toribio, Inés Inchausti‐Moya, Marina Toquero‐Asensio, Sonia García‐Díaz, Javier Sanchez‐Martinez, Carla Rodriguez‐Crespo, Silvia Galindo‐Carretero, Raquel Iglesia‐Aparicio, Celia Lopez‐Gonzalo, Ana Antón‐Contreras, Silvia Rojo‐Rello, Marta Dominguez‐Gil, Marta Hernández, Jose M. Eiros, Estanislao Nistal‐Villan, Iván Sanz‐Muñoz   +15 more
wiley   +1 more source

Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis

OncoTarget, 2016
Several of the growth factors and their receptor tyrosine kinases (RTK) such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and
Fiona Haxho, R. Neufeld, M. Szewczuk
semanticscholar   +1 more source

Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase

, 2012
This work was supported by the Medical Research Council and the Scottish Funding Council.Influenza virus sialidase has an essential role in the virus’ life cycle.
Russell, Rupert James Martin, Kerry, Philip Stephen, Rose, FJ, von Itzstein, M, Naffakh, N, Dyason, JC, van der Werf, S, Rameix-Welti, MA, Thomson, RJ, Rudrawar, S   +9 more
core   +1 more source

Complete analysis of the H5 hemagglutinin and N8 neuraminidase phylogenetic trees reveals that the H5N8 subtype has been produced by multiple reassortment events [PDF]

, 2016
The analysis of the complete H5 hemagglutinin and H8 neuraminidase phylogenetic trees presented in this paper shows that the H5N8 avian influenza has been generated by multiple reassortment events.
Dalby, A.R.
core   +1 more source

Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses

Nature Communications
Influenza B viruses are antigenically diverse and contribute significantly to the annual influenza burden. Here we report influenza B virus neutralizing single-domain antibodies that target highly conserved regions of the hemagglutinin and neuraminidase.
Arne Matthys, Jan Felix, Joao Paulo Portela Catani, Kenny Roose, Wim Nerinckx, Benthe Van Buyten, Daria Fijalkowska, Nico Callewaert, Savvas N. Savvides, Xavier Saelens   +9 more
doaj   +1 more source

Simple detection of mumps virus neuraminidase and anti-neuraminidase with the lectin neuraminidase test.

Acta virologica, 1983
The lectin neuraminidase (LN) test is based on specific interaction between Arachis lectin and the glycoprotein receptors treated with the neuraminidase (NA) of myxoviruses. The test is suitable for detection of mumps virus NA and of corresponding antibodies and is more sensitive than the conventional neuraminidase inhibition test.
P, Luther, H, Klamm, S, Weber
openaire   +1 more source

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

Antiviral Research, 2015
Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza (WHO CCs) tested 10,641 viruses collected by WHO-recognized ...
E. Takashita, A. Meijer, A. Lackenby, L. Gubareva, H. Rebelo-de-Andrade, T. Besselaar, A. Fry, V. Gregory, S. Leang, Wei-juan Huang, J. Lo, D. Pereyaslov, M. Siqueira, Dayan Wang, Gannon C.K. Mak, Wenqing Zhang, R. Daniels, A. Hurt, M. Tashiro   +18 more
semanticscholar   +1 more source